Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 01-1997 | 10-1996 | 07-1996 | 04-1996 | 01-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 20 | 20 | 142 | 152 |
| Marketable Securities | 80 | 170 | 60 | 160 | 25 |
| Receivables | 100 | 10 | 100 | 5 | 7 |
| Inventories | 70 | 70 | 50 | 100 | 57 |
| Other current assets | 50 | 20 | 40 | -166 | 34 |
| TOTAL | $320 | $290 | $270 | $240 | $275 |
| Non-Current Assets | |||||
| PPE Net | 1,084 | N/A | 1,084 | 1,084 | 1,084 |
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 11 |
| TOTAL | $1,094 | $10 | $1,094 | $1,094 | $1,095 |
| Total Assets | $780 | $760 | $760 | $740 | $790 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 40 | 40 | 40 | 50 | 89 |
| Accrued Expenses | 50 | 30 | 40 | 30 | 46 |
| Other current liabilities | 200 | 130 | 160 | 130 | 140 |
| TOTAL | $320 | $250 | $260 | $260 | $304 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 6 | N/A | 18 |
| Other Non-Current Liabilities | 30 | 30 | 30 | 0 | 0 |
| TOTAL | $30 | $30 | $36 | $30 | $52 |
| Total Liabilities | $350 | $280 | $296 | $290 | $356 |
| Shareholders' Equity | |||||
| Common Shares | 9 | 9 | 9 | 9 | 8 |
| Retained earnings | -5,450 | -5,390 | -5,410 | -5,440 | -5,443 |
| Other shareholders' equity | 562 | 5,862 | 562 | 562 | 561 |
| TOTAL | $420 | $480 | $460 | $430 | $434 |
| Total Liabilities And Equity | $770 | $760 | $756 | $720 | $790 |